Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data & AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma & Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2021 / Mar / Sniffing Out Prostate Cancer with Artificial Neural Networks
Clinical Chromatography Gas Chromatography Mass Spectrometry

Sniffing Out Prostate Cancer with Artificial Neural Networks

Machine-based cancer detection system mimics the canine nose

By Olivia Gaskill 03/11/2021 1 min read

Share

Though prostate cancer is the second-highest cause of cancer death in men, early biomarker detection methods – specifically, the prostate-specific antigen screening test – lack sensitivity and specificity. We need to reduce false positives and false negatives – but how? The answer may lie in our four-legged friends. Trained canines have been shown to reliably detect and diagnose cancer by smell. Granted, dogs in the lab would be a logistical nightmare and not feasible for mass testing – but that’s where researchers at Massachusetts Institute of Technology (MIT) come in.

Using urine samples from patients with or without prostate cancer (confirmed by biopsy), they tested whether the cancer could be detected by trained sniffer dogs, molecular volatile organic compound (VOC) analysis by gas chromatography-mass spectroscopy (GC-MS), or microbiota profiling (1). Canine olfaction reliably distinguished between prostate cancer samples and biopsy-negative controls, whereas VOC and microbiota detected qualitative differences between the groups.

From this, the team trained an artificial neural network to mimic canine olfactory diagnosis – distinguishing between biopsy-positive and biopsy-negative samples based on the GC-MS data both alone and combined with canine olfaction data. “We knew that the sensors are already better than what the dogs can do in terms of the limit of detection, but what we haven’t shown before is that we can train an artificial intelligence to mimic the dogs,” said Andreas Mershin, a research scientist at MIT and author on the study (2). “And now we’ve shown that we can do this – we’ve shown that what the dog does can be replicated to a certain extent.”

This multiparametric approach lays the groundwork for the development of machine-based diagnostic tools that mimic canine olfaction – and, given the dogs’ keen sense of smell, it has the potential to improve diagnostic efficacy in a field where unreliable results run rampant.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. C Guest et al., PLoS One, 16, e0245530 (2021). PMID: 33596212.
  2. MIT News (2021). Available at: http://bit.ly/307Yl0K.

About the Author(s)

Olivia Gaskill

During my undergraduate degree in psychology and Master’s in neuroimaging for clinical and cognitive neuroscience, I realized the tasks my classmates found tedious – writing essays, editing, proofreading – were the ones that gave me the greatest satisfaction. I quickly gathered that rambling on about science in the bar wasn’t exactly riveting for my non-scientist friends, so my thoughts turned to a career in science writing. At Texere, I get to craft science into stories, interact with international experts, and engage with readers who love science just as much as I do.

More Articles by Olivia Gaskill

False

Advertisement

Recommended

False

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.